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Abstract
Nocturnin is a circadian clock-regulated deadenylase thought to control mRNA expression post-transcriptionally through
poly(A) tail removal. The expression of Nocturnin is robustly rhythmic in liver at both the mRNA and protein levels, and mice
lacking Nocturnin are resistant to diet-induced obesity and hepatic steatosis. Here we report that Nocturnin expression is
regulated by microRNA-122 (miR-122), a liver specific miRNA. We found that the 39-untranslated region (39-UTR) of
Nocturnin mRNA harbors one putative recognition site for miR-122, and this site is conserved among mammals. Using a
luciferase reporter construct with wild-type or mutant Nocturnin 39-UTR sequence, we demonstrated that overexpression of
miR-122 can down-regulate luciferase activity levels and that this effect is dependent on the presence of the putative miR-
122 recognition site. Additionally, the use of an antisense oligonucleotide to knock down miR-122 in vivo resulted in
significant up-regulation of both Nocturnin mRNA and protein expression in mouse liver during the night, resulting in
Nocturnin rhythms with increased amplitude. Together, these data demonstrate that the normal rhythmic profile of
Nocturnin expression in liver is shaped in part by miR-122. Previous studies have implicated Nocturnin and miR-122 as
important post-transcriptional regulators of both lipid metabolism and circadian clock controlled gene expression in the
liver. Therefore, the demonstration that miR-122 plays a role in regulating Nocturnin expression suggests that this may be an
important intersection between hepatic metabolic and circadian control.
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Introduction
Nocturnin is a circadian deadenylase [1,2], which removes
poly(A) tails from its target RNAs, and is thought to control target
RNA expression by either enhancing RNA degradation or
silencing translation. Nocturnin shows rhythmic expression in many
tissues such as spleen, kidney and heart in mice and this
rhythmicity is particularly robust in liver [3]. Nocturnin is also an
immediate early gene, and its expression is acutely induced by
stimuli such as serum and 12-O-tetradecanoyl-phorbol-13-acetate
(TPA) in cultured cells [2]. Mice lacking Nocturnin (Noc
2/2) are
resistant to diet-induced obesity and hepatic steatosis [4]. Although
the expression of ‘core’ circadian clock genes is not affected in
Noc
2/2 mice, expression profiles of rhythmic ‘output’ genes such
as Srebp1c and Pparc, key regulators of lipid-related gene
expression, are significantly changed [4]. These and other data
indicate that Nocturnin is important for proper lipid metabolism.
MicroRNAs (miRNAs) are short (19–25 nt), noncoding RNA
molecules that can regulate their target gene expression post-
transcriptionally [5]. MiRNAs are transcribed, capped, adenylated
and spliced just as protein-coding mRNAs, and these primary
transcribed miRNAs (pri-miRNAs) are then cleaved by Drosha,
which is an RNaseIII endonuclease, in the nucleus, releasing the
shorter (265 nt long) precursor miRNA (pre-miRNA). Subse-
quently, pre-miRNAs are exported into the cytoplasm, and are
further digested by Dicer, which is an endonuclease that cleaves
double-strand RNA or pre-miRNAs, and become a short duplex
RNA. This duplex RNA is incorporated into the functional
miRNA-induced silencing complex (miRISC) where target
mRNAs are recognized and processed [6,7]. miRNAs recognize
target sequences usually in the 39-UTRs of target mRNAs with a
requirement for a nearly perfect match between the 59-proximal
‘seed’ region (position 2–8) of the miRNA and its target mRNA for
binding specificity [7,8]. Once the miRNA recognizes and
interacts with its target RNA, it generally results in inhibition of
protein synthesis and/or triggers deadenylation and degradation,
although the detailed mechanisms are still in debate [6,7].
In mammals, more than 50% of all protein-coding mRNAs are
predicted to be targets of a miRNA, therefore most, if not all,
biological processes seem to be controlled by miRNAs to some
degree [6]. Contributions of circadian clock function to miRNA or
vice versa have been demonstrated. Rhythmic expression of
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nucleus (SCN), the site of the circadian pacemaker [9,10]. Other
miRNAs such as miR-132 and miR-219 are functionally involved
in the clock and regulate circadian period or light dependent
resetting of the clock in the SCN [9]. Also several mammalian core
clock genes such as Period1, 2, 3 and Clock as well as Drosophila Clock
have been demonstrated to be targets of miRNAs [11,12,13].
MicroRNA-122 (miR-122) is a liver-specific miRNA. It is the
most abundant miRNA in this organ accounting for approxi-
mately 70% of the total miRNA population [14]. Proper miR-122
expression is important for normal liver function [15,16]. Blocking
miR-122 expression leads to the reduction of plasma cholesterol
and triglyceride levels in both rodents and primates, [15,17,18,19].
Moreover, mice in which miR-122 is knocked down are resistant
to diet-induced hepatic steatosis [18], supporting a role for this
miRNA in fatty acid and cholesterol metabolism in liver. In
humans, the level of miR-122 is repressed in hepatocellular
carcinomas and in patients with nonalcoholic steatohepatitis
[20,21]. There is also a functional connection between miR-122
and circadian rhythms, because the transcription of miR-122 is
rhythmic, and circadian transcripts are enriched in a gene set that
is misregulated by miR-122 knock-down in vivo [22].
Many mRNAs have been predicted to be potential targets of
miR-122, but only a few genes such as cationic amino acid
transporter1 (Cat1), cyclinG1, or Smarcd1/Baf60a have been
demonstrated to be bona fide targets [15,22,23,24,25]. In this study,
we identified Nocturnin as one of the target mRNAs of miR-122 in
mouse liver and we propose that miR-122 is important for shaping
the appropriate circadian expression profile of Nocturnin.
Results and Discussion
Nocturnin is a target of miR-122 in cultured cells
Although target mRNAs frequently have multiple copies of
miRNA target sites in their 39-UTR [7], examination of the
Nocturnin mRNA sequence revealed a single potential target
sequence for miR-122 in its 39-UTR (Fig. 1A). However, this
single site contained a miR-122 seed sequence that was highly
conserved in human, mouse, rat, and cow (Fig. 1B).
In order to test whether this sequence was indeed a miR-122
recognition site, we used a cell-based luciferase reporter system in
which the mouse Nocturnin 39-UTR was cloned downstream of the
Firefly luciferase gene. We also generated constructs in which the
7 bp ‘‘seed’’ sequence (CACUCCA) within the putative miR-122
site was either mutated or deleted (Fig. 2A). When miR-122 was
expressed in NIH3T3 cells with the WT Nocturnin 39-UTR, we
observed a dose-dependent decrease in relative luciferase activity
(Fig. 2B). In contrast, miR-122 overexpression did not affect the
luciferase activity of constructs with mutated or deleted miR-122
target sequences (Fig. 2B). Similar results were obtained in
HEK293 cells as well (data not shown). These results indicated
that Nocturnin is a potential direct target of miR-122, and miR-122
recognizes the putative recognition site present in the Nocturnin 39-
UTR.
Since most mRNAs undergo either deadenylation and degra-
dation and/or inhibition of protein synthesis after miRNA
recognition and binding [6,7], we investigated whether miR-122
overexpression affected the Nocturnin 39-UTR reporter RNA levels.
Figure 1. The Nocturnin 39UTR possesses one putative miR-122
recognition site. A. The sequence of WT Nocturnin 39-UTR (top) and
miR-122 (bottom) around the putative miR-122 recognition site. Black
and gray lines represent the perfect match and G-U wobbles,
respectively. B. miR-122 recognition sequences of Nocturnin gene in
Homo sapiens (NM_012118; nt1930–1953), Mus musculus (NM_009834,
nt2100–2121), Rattus norvegicus (NM_138526, nt1680–1702), and Bos
taurus (NM_001082454, nt1693–1715). Red characters represent the
seed sequence for miR-122 recognition.
doi:10.1371/journal.pone.0011264.g001
Figure 2. miR-122 down-regulates Nocturnin WT luciferase
reporter activity but not its RNA level. A. Schematic representa-
tion of the Nocturnin 39-UTR luciferase reporter genes. Nucleotide
sequences of mutations introduced into Mut and Del reporters are also
shown. X and D denote mutation and deletion of WT Nocturnin 39-UTR,
respectively. Luc; luciferase, BGH; Bovine growth hormone polyadenyl-
ation signal. B. Relative luciferase activities (means 6 S.E. Three
independent experiments in duplicate) of Nocturnin 39-UTR reporters
with various levels of miR-122 overexpression in NIH3T3 cells. Firefly
luciferase activity was normalized to Renilla luciferase activity. The
firefly/Renilla ratios without miR-122 expression were set as 1 for each
reporter gene. Asterisks represent p,0.005 versus no miR-122
overexpression (white bars). C. Relative RNA levels of reporter genes
(means 6 S.E. Two independent experiments in duplicate) with miR-122
overexpression in NIH3T3 cells. Firefly luciferase level was normalized to
Renilla luciferase level.
doi:10.1371/journal.pone.0011264.g002
miR-122 Modulates Nocturnin
PLoS ONE | www.plosone.org 2 June 2010 | Volume 5 | Issue 6 | e11264Although the overall RNA levels of control reporter (lacking any of
the Nocturnin 39-UTR) were higher than those containing the 39-
UTR sequence, in no case was there an effect of miR-122 (Fig. 2C).
Therefore, the changes in luciferase activity must be due to miR-
122 mediated inhibition of protein synthesis rather than to RNA
decay.
Interaction between Nocturnin and miR-122 is specific
In order to investigate the specificity of miR-122 towards
Nocturnin, we tested whether miR-125a or miR-125b could reduce
the activity of the Nocturnin 39-UTR reporter. These two miRNAs
are highly expressed in brain, heart and lung, and some genes such
as lin-28 and ERBBs have been identified as their targets
[26,27,28], but the Nocturnin 39-UTR does not contain putative
miR-125a or 125b sequence recognition motifs. When these
miRNAs were co-expressed with Nocturnin 39-UTR reporter genes,
both miR-125a and -125b failed to repress the luciferase activity of
Nocturnin 39UTR WT, even under conditions where miR-122 was
able to effectively repress reporter gene expression (Fig. 3A). The
failure to repress the Nocturnin 39-UTR WT luciferase level by
miR-125a or -125b was not due to the absence of miRNA
expression, since Northern blot analysis showed that the miRNAs
are well expressed in HEK293 cells (Fig. 3B).
miR-122 expression is not rhythmic
Since Nocturnin expression exhibits high amplitude rhythms in
liver [3,4], we tested whether miR-122 expression might also be
rhythmic in liver. The mature form of miR-122 expression was not
rhythmic (Fig. 4; white arrowhead), consistent with the fact that
the half-life of miRNAs can be well over 24 hours [29]. However,
we detected another more slowly migrating band in our Northern
blot analysis, which was rhythmic with highest levels at night
(Fig. 4; black arrowhead) and probably corresponded to pre-miR-
122. These results are consistent with the previous report that the
expression of both pri-miR-122 and pre-miR-122 is rhythmic but
that mature miR-122 is not [22].
The deadenylase activity of Nocturnin is not necessary for
miR-122 mediated self regulation
MiRNAs not only repress translation but can also trigger
deadenylation and degradation and/or translational silencing of
their target mRNAs [30,31]. Since the Nocturnin gene encodes a
deadenylase, we wondered whether Nocturnin’s deadenylation
activity could contribute to the miR-122 effect on the Nocturnin
message. We thus co-expressed miR-122 and Nocturnin reporter
genes (Fig. 2A) in Mouse Embryonic Fibroblasts (MEFs) derived
from Noc
+/+, Noc
+/2, and Noc
2/2 mice to see if loss of a functional
Nocturnin deadenylase would affect the down-regulation of
Nocturnin expression mediated by miR-122. However, no signifi-
cant difference in miR-122’s ability to down-regulate the
expression of Nocturnin 39-UTR reporter was observed between
genotypes (Fig. 5A), suggesting that the deadenylase activity of
Nocturnin is not necessary for miR-122 to down-regulate Nocturnin
expression. Loss of Nocturnin expression also did not affect the
expression level of miR-122 in mouse liver (Fig. 5B).
Endogenous Nocturnin is a target of miR-122 in vivo
To test whether the effects of miR-122 on Nocturnin in cell
culture could also be observed in vivo, we analyzed endogenous
expression of Nocturnin in liver using mice in which miR-122
expression was knocked down by injecting miR-122 specific
antisense oligonucleotides (ASOs).
Four doses of miR-122 ASO or PBS control were injected
intraperitoneally into mice, and 14–15 days after the first injection
(corresponding to 2–3 days after the last injection), livers were
harvested around the clock at 4hr intervals. Analysis of livers from
miR-122-depleted animals relied on the same samples as in [22].
As described in [22], miR-122 depletion was .85% on average,
but showed some time point-dependent variation due to the
rhythmic production of miR-122. Nocturnin mRNA expression
remained rhythmic after miR-122 ASO administration, but the
Figure 3. Effect of miR-122 on Nocturnin reporter expression is
specific. A. Relative luciferase activities (means 6 S.E. Two independent
experiments in triplicate) when reporter genes were co-transfected with
either miR-122, miR-125a, or miR-125b in NIH3T3 cells. Asterisks
represent p,0.005 miR-122 versus no miR-122, miR-125a, or miR-125b.
B. Northern blot analysisofmiRNAs.Same amount ofplasmid DNA(1 mg)
to express miR-122, -125a, and -125b was transfected into HEK293 cells.
doi:10.1371/journal.pone.0011264.g003
Figure 4. Mature miR-122 expression is not rhythmic in liver.
The levels of miR-122 were determined by Northern blotting from liver
samples taken at various circadian times as indicated. One mouse per
time point was used. U6 snRNA was measured as a loading control.
White and black arrowheads indicate mature miR-122 and pre-miR-122,
respectively.
doi:10.1371/journal.pone.0011264.g004
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was more significant at ZT12 and 16 (ZT refers to Zeitgeber Time
and ZT0 is defined as time (hours) of lights on and ZT12 is defined
as time of lights off) compared to other time points, corresponding
to times when the expression of Nocturnin is usually high. These
data were consistent with previous reports that listed Nocturnin
mRNA as one of a set of mRNAs that were up-regulated by
knocking down miR-122 in vivo [15,18]. Although overexpression
of miR-122 did not affect the RNA level of the Nocturnin reporter
gene (Fig. 2C), the knock down of miR-122 was able to
significantly increase Nocturnin mRNA levels in mouse liver. This
could be due to the difference between synthetic reporter gene vs.
endogenous mRNA or the difference between cultured cell system
vs. in vivo system.
Endogenous Nocturnin protein expression was also measured
around the clock with or without miR-122 ASO, and we found
that Nocturnin protein was significantly higher during the night
(ZT12) in the miR-122 ASO injected mice than in those injected
with PBS (Fig. 6B). In an independent set of animals we
furthermore confirmed that injection of a control ASO, specific
for the brain-specific miR-124, did not increase Nocturnin levels at
the two time points tested, ZT0 or ZT12 (Fig. 6C). The larger
effect of miR-122 ASO at night is likely due to the high levels of
Nocturnin mRNA during this phase of the circadian cycle. Nocturnin
mRNA expression is tightly regulated in liver peaking at ZT12
(Fig. 6A), and its amplitude can be almost 100-fold [3]. Our data
thus demonstrate that this robustly rhythmic expression of
Nocturnin in liver is shaped, at least in part, by miR-122.
It has becomeincreasinglyclearthat miRNAsplaya role inmany
biological processes such as development, cell proliferation/
differentiation, apoptosis, and metabolism, and misregulation of
miRNA expression can lead to pathological conditions including
cancer, autoimmunity, and obesity [6]. Obesity and/or metabolic
syndrome have become a major health problem especially among
westerncountries,and several reportshaveindicated that there isan
Figure 5. Deadenylase activity of Nocturnin was not involved in
miR-122-mediated self-regulation. A. Relative luciferase activities
(means 6 S.E. Three independent experiments in duplicate) with miR-
122 overexpression in MEFs (White bars; +/+, Gray bars; +/2, Black bars;
2/2). Luciferase activities were normalized as described in Figure 2.
Asterisks represent p,0.005 versus no miR-122. B. miR-122 expression
was measured from Noc
+/+ and Noc
2/2 livers. RNA samples are pools of
equal amounts of RNA from each circadian time point (ZT 0, 4, 8, 12, 16,
and 20, one mouse per time point).
doi:10.1371/journal.pone.0011264.g005
Figure 6. Nocturnin is up-regulated by miR-122 knock-down in
vivo.A . Nocturnin mRNA expression was measured by qRT-PCR from
livers collected at the times indicated from mice that were previously
treated with miR-122 ASO or PBS (mean 6 S.E.). Each time point
represents an average from three mice. p,0.05 by two-way ANOVA
(PBS vs. miR-122 ASO). B. Nocturnin protein expression in PBS or miR-
122 ASO treated mouse liver (mean 6 S.E.) around the clock was
measured on Western blots and then quantitated using Image J
software. Each point represents average of three mice. Two-way ANOVA
(PBS vs. miR-122 ASO) was not significant (p=0.32). C. Representative
Western blots of Nocturnin expression in PBS, miR-122 ASO, or miR-124
ASO treated mouse liver (two mice per group) at ZT0 and ZT12. An
independent set of mice as that in panels A and B was used. D.
Nocturnin protein expression in PBS, miR-122 ASO, or miR-124 ASO
treated mouse liver (mean 6 S.E.) at ZT0 and ZT12. Western blots
(Fig. 6C) were quantitated using Image J software. Each point
represents an average of two mice.
doi:10.1371/journal.pone.0011264.g006
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or metabolic syndrome. For example, the expression of miR-27,
-335, and -519d is up-regulated in liver and/or adipose tissue of
obese mice or humans [32,33,34,35,36]. In addition, the proper
expression of miR-122 in liver is critical for lipid metabolism, since
overexpression of miR-122 increased and knockdown of miR-122
decreased cholesterol and fatty acid biosynthesis [15,18]. Nocturnin
is also important for proper lipid metabolism in liver, since Noc
2/2
mice manifest hepatic steatosis under high-fat diet conditions and
are resistant to diet-induced obesity [4]. Furthermore, both miR-
122 and Nocturnin are implicated to play a role in circadian rhythms
[4,22]. Taken together, our findings suggest that the regulation of
Nocturnin expression by miR-122 is an important connection
between circadian clocks and hepatic lipid metabolism.
Materials and Methods
Plasmid DNA constructs
The mouse Nocturnin 39-UTR was cloned from mouse liver
cDNA by PCR. The PCR was performed at 95uC for 5 min as the
initial step and then for 30 cycles of 95uC for 30 s, 55uC for 30 s,
and 72uC for 2 min, followed by a final extension of 1 cycle of
72uC for 7 min, utilizing the following primers; mNoc3UTRF 59-
CTAGATCACAAGCGTCTTAACCAGGG-39, mNoc3UTRR
59- TCTAGAACTTTATAAATAAGATATTTACCATTTTA-
CCACTGG-39. Then, the PCR product was cloned into pCR2.1
-TOPO (Invitrogen). Subsequently, mutations into the putative
miR-122 recognition site were introduced by QuikChange Site
Directed Mutagenesis kit (Stratagene). The reactions were
performed at 94uC for 5 min as the initial step and then for 18
cycles of 94uC for 30 s, 55uC for 1 min, and 68uC for 14 min,
followed by a final extension of 1 cycle of 72uC for 7 min with the
following primers; mNocmiR122mutF 59- CCCGCATTGA-
AAAGGTGTTTGGTGAGGTGTTTGAGCTTGTTG-39 and
mNocmir122mutR 59- CAACAAGCTCAAACTGGAGTGCA-
AACACCTTTTCAATGCGGG-39 for mNoc 39-UTR mut, and
mNocmiR122delF 59- CCCGCATTGAAAAGGTGTTTGGT-
TTGAGCTTGTTGTTCATCTGTG-39 and mNoc miR122-
delR 59- CACAGATGAACAACAAGCTCAAACCAAACACC-
TTTTCAATGCGGG-39 for mNoc 39-UTR del. All three
Nocturnin 39-UTR clones (WT, Mut, and Del) in pCR2.1-TOPO
vector were verified by sequencing. Then, these inserts were
removed from pCR2.1-TOPO by BamHI/ApaI digestion, and
ligated into pELSB luciferase reporter vector [37].
For miRNA expression plasmids, genomic sequences of
respective miRNAs were first amplified by PCR. The PCR was
performed at 94uC for 5 min as the initial step and then for 40
cycles of 94uC for 30 s, 58uC (miR-122) or 55uC (miR-125a and
miR-125b) for 30 s, and 72uC for 1 min, followed by a final
extension of 1 cycle of 72uC for 7 min, utilizing the following
primers; miR122F 59-GTATGATGTGGTTTGTAAGAAGTG-
TCTGCC-39, miR122R 59-GTGTCAGGGTAGTCAGTGTT-
GGG-39, miR125aF 59-GCCAATGTCTCTAGGGTTCTAGA-
AGC-39, miR-125aR 59-CAGCTGGCAGACACGGAGGC-39,
miR125bF 59-CCTGGGCCCACAGTAACAGTTG-39, miR125bR
59-GGGCCCCATTAACTGGCATATAATCC-39.T h eP C Rp r o d -
ucts were first cloned into pCR2.1-TOPO, and sequences were
verified. Then, inserts were cut out by BamHI/EcoRV (miR-122 and
miR-125a) or SpeI/NotI (miR-125b) and ligated into pcDNA3.1/V5-
HisB (Invitrogen).
Cells and Animals
Mouse Embryonic Fibroblast (MEF) cells were derived from E14
embryosofNocturninknockoutmice(Noc
2/2),Nocturninheterozygous
mice (Noc
+/2) or their wild-type counterparts (Noc
+/+). All the
MEFs, mouse NIH3T3 cells and human HEK293 cells were
grown in Dulbecco’s Modified Eagle Medium (Invitrogen) with
10% fetal bovine serum (ATLANTA biologicals) at 37uCw i t h
5% CO2.
Mice were maintained on a 12:12 LD cycles and fed ad libitum.
Animal experiments were conducted following the protocols
approved by the Institutional Animal Care and Use Committees.
Antisense oligonucleotide (ASO) treatment was performed as
previously described [22]. Briefly, ASO treatment was performed
in 11-week male C57BL/6 mice (Elevage Janvier, Le Genest St
Isle, France) by intraperitoneal injection. The ASOs were chimeric
29-fluoro/29-O-methoxyethyl modified oligonucleotides with a
completely modified phosphorothioate backbone. The exact
chemistry is available on request. Mice were allowed to adapt to
a 12 hr/12 hr LD regimen for 10 days and then (days 11, 15, 18
and 22; at ZT6 or ZT22) received 4 doses of 20 mg ASO/kg body
weight in 150 ml, or 150 ml of saline (PBS control). On days 24
and 25 (i.e. 2–3 days after the last injection), animals were
sacrificed at the respective ZTs, and livers were snap-frozen in
liquid nitrogen.
DNA Transfections
Transfection was carried out using FuGENE6 (Roche) for
NIH3T3 and HEK293 cells, or Lipofectamine 2000 for MEFs,
according to manufacturer’s instructions. Two days after trans-
fection, cells were washed with phosphate-buffered saline (PBS)
and harvested in 150 ml of passive lysis buffer (Promega). For
induction of ecdysone-mediated transcription, Ponasterone A
(5 mM) (Invitrogen) was added to the culture medium 20 h prior
to harvesting the cells. Luciferase activities were assayed with the
Dual-Luciferase Reporter Assay System (Promega) using Turner
Designs Model 20 luminometer (Turner). The Renilla luciferase
plasmid was cotransfected to normalize each transfection assay.
For Fig. 2B and 3A, 24 well plates were used for luciferase
measurement. Amounts of DNA that were transfected were as
follows; 50 ng firefly reporter genes, 15 ng pRL-CMV (Renilla
luciferase), 50 ng pVgEcR-RXR, pmiR-122 (0 ng, 10 ng, 50 ng,
100 ng, 200 ng, and 400 ng, respectively for Fig. 2B or 100 ng of
pmiR-122, 125a and 125b for Fig. 3A) and pcDNA3.1 to obtain a
total amount of 515 ng (Fig. 2B) or 415ng (Fig. 3A) of DNA per
well. For Fig. 2C, 6 well plates were used for RNA measurement.
Amounts of DNA that were transfected were as follows; 150 ng
firefly reporter genes, 45 ng pRL-CMV (Renilla luciferase), 150 ng
pVgEcR-RXR, pmiR-122 (0 ng, 30 ng, and 600 ng, respectively)
and pcDNA3.1 to obtain a total amount of 1545 ng of DNA per
well.
qPCR Analysis
Total RNA was extracted from NIH3T3 cells with TRIZOL
reagent (Invitrogen), followed by DNaseI treatment twice (Ambion),
iScript cDNA synthesis kit (Bio-Rad) was used for reverse
transcription, and the levels of firefly and Renilla luciferase mRNA
were examined by MyiQ real-time PCR machine (Bio-Rad) using iQ
SYBR Green Supermix (Bio-Rad). The primer sequences were as
follows: pGL3-lucF, 59-CTGATTTTTCTTGCGTCGAGTTT-39;
pGL3-lucR, 59- GCGCGGAGGAGTTGTGTTT-39;p R L - l u c F ,
59-ACATGGTAACGCGGCCTCTT-39; and pRL-lucR, 59-TG-
CCCATACCAATAAGGTCTGGTA-39. The amount of the firefly
luciferase mRNA was normalized against that of the Renilla luciferase
mRNA, and the relative mRNA abundance was calculated using
Pfaffl Ct method [2].
For ASO-treated mice, RNA was prepared as previously
described [22]. Primers used were as follows; NocF, 59-ACCAGC-
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TGCCT-39, 45srRNAF, 59-TGCTGATTGCTTGTTTGGTC-
39; 45srRNAR, 59-ACACCCGAAATACCGATACG-39.
Northern Blot
RNAs were extracted from HEK293 cells by TRIZOL, and
equal amounts of total RNA were denatured and fractionated by
electrophoresis on a 15% polyacrylamide-8M Urea gel. After
electroblotting and cross-linking onto Hybond-N
+ membrane
(Amersham), the blots were probed at 42uC in QuickHyb
(Stratagene) with terminally radiolabeled oligonucleotides com-
plementary to miR-122 (59-ACAAACACCATTGTCACACTC-
CA-39), miR-125a (59-TCACAGGTTAAAGGGTCTCAGGGA-
39) miR-125b (59-TCACAAGTTAGGGTCTCAGGGA), or U6
(59-CATCCTTGCGCAGGGGCCATGC-39), followed by wash-
ing with 26SSC (16SSC is 0.15 M NaCl plus 0.015 M sodium
citrate)-0.1% sodium dodecyl sulfate (SDS), and then with 0.56
SSC-0.1% SDS at 42uC.
Western Blot
Mouse liver samples were homogenized in RIPA buffer (50mM
Tris-HCl, 150mM NaCl, 2mM EDTA, 0.5% Sodium deoxycho-
late, 1% Igepal CA-630, 5mM DTT), containing protease
inhibitor (SIGMA). Equal amounts of each sample were separated
by electrophoresis on an SDS-10% polyacrylamide gel before
transfer to PVDF membrane (Bio-Rad). The membrane was then
blocked with BLOTTO solution (0.1% Tween 20 and 5% dry
nonfat milk powder in Tris-buffered saline [TBS], pH 7.4) for 1 hr
at room temperature. The membrane was treated with the
primary antibody, anti-Nocturnin antibody (Gift of Garbarino-
Pico, E.) or anti-TUBULIN (SIGMA) overnight at 4uC. After
washing, the blots were treated with secondary antibodies
conjugated to horseradish peroxidase, and developed with
chemiluminescence Western blotting kit (Roche) or ECL plus
(Amersham).
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